Endocrine oncology

Rural-Urban Disparities in the Continuum of Thyroid Cancer Care: Analysis of 92,794 Cases

ThyroidPublished Retrospective cohort study

Authors' conclusion

Compared to their urban counterparts, rural and frontier patients with thyroid cancer present with later-stage disease and experience higher disease-specific mortality.

Study context

Population
Patients diagnosed with thyroid cancer (1999–2017), linked California Cancer Registry and California Office of Statewide Health Planning and Development databases; 70.6% women, mean age 50.0 years
Participants
92,794 patients
Exposure
Rural and frontier vs urban residence
Outcome
Distant disease at diagnosis (cases per 1000 new cases)
Follow-up
Diagnosis
Methodological detailspopulation-based registry, linked databases, Cox and logistic regression with stepwise covariate adjustment
  • Population-based registry
  • Linked databases
  • Cox and logistic regression with stepwise covariate adjustment

Main finding

As reported in the abstract

  • Rural vs Urban: P < 0.01
  • Frontier vs Urban: P < 0.01

Observational data: associations, not effects.

Further findings

OutcomeOR (CI)
Lost to follow-upRuralvs Urban1.69 (1.54–1.85)
Lost to follow-upFrontiervs Urban3.03 (1.89–5.26)
Disease-specific mortalityRuralvs Urban1.18 (1.07–1.30)
Disease-specific mortalityFrontiervs Urban1.92 (1.22–2.77)
OutcomeP value
Incidence of MTCRural vs Urban · 17.9 vs. 13.6 cases per 1000P < 0.01
Incidence of MTCFrontier vs Urban · 31.0 vs. 13.6 per 1000P < 0.01
Incidence of ATCFrontier vs Urban · 15.5 vs. 7.1 per 1000P < 0.01

Lost to follow-up

Rural and frontier residence independently associated with being lost to follow-up

Original publication

Rural-Urban Disparities in the Continuum of Thyroid Cancer Care: Analysis of 92,794 Cases. Thyroid. Published 22 January 2024. doi:10.1089/thy.2023.0357

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.